Policies & RegulationsPharmacyHospitalsPharma & DistributionDrug ApprovalsIP IssuesDomestic NDD
  news bulletin  
KMA representatives questioned Noh’s decision
by Eui Kyoung Yoon (ekyeun@dreamdrug.com)
Published : Apr 1, 2014 04:10:45
KMA representatives questioned why Noh Hwan Kyu, President of the KMA, accepted the government suggestion of a 6-month pilot program for virtual doctor visits.

Over 180 representatives who gathered for a vote asked Noh to explain his latest decision to accept the pilot program.

Noh responded, “The government has never executed any pilot program for virtual doctor visits. We need to object the proposal with some evidence, but there was nothing. That’s why we accepted the pilot program (that is doomed to fail).”

He added, “We need the evidence the virtual doctor visits are related to misdiagnoses. Nobody would trust the possibility without the pilot program.”

He said, “But we had health insurance issues resolved clearly while accepting the pilot program the government really wanted to push.”
 
Reply 0
Name Password
Text
 
Popular News
 
Champix to be covered, starting Feb 2015
First generic version of Omacor approved
OTC drugs will be available at some resorts
Novartis Korea and KPWA agreed on margin increase
MSD’s new COX-2 inhibitor Arcoxia approved
All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted,
displayed, published or broadcast without the prior consent of dailypharm.com